News for Nano-X Imaging Ltd. (NNOX)

On June 6, 2025, Nano X Imaging (NNOX) received a reiteration of its "Buy" rating from D. Boral Capital, as stated by analyst Jason Kolbert. The firm has decide

HealthOST identifies vertebral height loss and bone mineral density, which are key indicators of musculoskeletal diseaseOsteoporosis is a common p...

Management to present on Wednesday, June 11 at 1:45 PM ET PETACH TIKVA, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ( NNOX) (”œNanox” or

Operator: Good day, and thank you for standing by. Welcome to the Nano-X Imaging Ltd. Q1 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.

On May 23, 2025, analyst Jason Kolbert from D. Boral Capital issued a new report on Nano X Imaging (NNOX), a healthcare company listed on NASDAQ. According to t

Revenue: $2.8 million for Q1 2025, compared to $2.6 million in Q1 2024.Net Loss: $13.2 million for Q1 2025, compared to $12.2 million in Q1 2024.Gross Loss: $3

May 22, 2025 / 12:30PM GMTOperator Good day, and thank you for standing by. Welcome to the Nano-X Q1 2025 Earnings Conference Call. (Operator Instructions) Plea

Nano-X Imaging Ltd. (NASDAQ:NNOX) Q1 2025 Earnings Conference Call May 22, 2025 8:30 PM ETCompany ParticipantsMike Cavanaugh - Investor RelationsErez...

Key Highlights for Investors: EPS Miss: Nano-X Imaging reported a Q1 GAAP EPS of -$0.21, missing estimates by $0.02. Revenue Increase: Revenue grew by 10

In its latest financial update, Nanox (NNOX) disclosed first-quarter revenue of $2.8 million, falling short of the expected $3.98 million. Despite this, the com

Nanox (NNOX) secures FDA 510(k) clearance, paving the way for advanced medical imaging access. Analysts project significant upside potential, with the a

Quick Summary: Nano-X Imaging (NNOX) has gained significant momentum with U.S. FDA clearance for its Nanox.ARC X device. Analysts set a promising target

Key Takeaways: Nano-X Imaging's revenue and EPS miss analysts' expectations, yet the company projects robust annual revenue growth. Analyst price targets

First FDA clearance for Nanox.ARC X to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indicatio

First FDA clearance for Nanox.ARC X to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paran...

Operator: Good day and thank you for standing by. Welcome to the Nano-X Fourth Quarter 2024 Earnings Call. At this time, all participants are in listen-only mode.

Nano-X Imaging Ltd. (NASDAQ:NNOX) Q4 2024 Earnings Conference Call March 31, 2025 8:30 AM ETCompany ParticipantsMike Cavanaugh - Investor RelationsErez...

We recently published a list of Top 8 AI News Updates Investors Should Not Miss. In this article, we are going to take a look at where Nano-X Imaging Ltd. (NASDAQ:NNOX) stands against other top AI news updates investors should not miss. The global AI industry is growing at a rapid pace but a looming […]

Nano-X Imaging (NNOX) is set to report its fourth-quarter financial results on March 31 before the market opens. Analysts project an earnings per share (EPS) of